David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, Co-Founder and President at Every Cure, shared on LinkedIn:
“Thrilled to see our paper – the largest study of pediatric Castleman disease natural history and treatment – published and able to be used by clinicians to treat their pediatric patients.
Please help to share this post so doctors are aware of this study and patients can benefit!
Grateful to Bridget Austin, Sheila Pierson, and Joshua Brandstadter for their hard work and leadership of this important study.”
Title: Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
Authors: Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter
Read the Full Article.
Other articles about pediatric cancer on OncoDaily.